Amount Raised
$43 Million
Round Type
Series A
Description
CereVasc, Inc., a company focused on improving the treatment of patients with hydrocephalus, announced today the closing of an expanded Series A financing that raised a total of $43.9 million led by the Perceptive Xontogeny Venture (PXV) Fund and ATON Partners, LLC.
Who else raised in Biotechnology around the same time
Companies in the same sectors as CereVasc that raised within 45 days of this round, from Fundz verified event records.
- Azure Health Technology Ltd raised $353K (Seed) on July 24, 2020.
- Elucidata raised $880K on July 23, 2020.
- Tasso raised $17M on July 23, 2020.
- TriFlo Cardiovascular Inc raised $4.6M (Seed) on July 22, 2020.
- Nanoscope Therapeutics raised $13M on July 22, 2020.
- Revalesio raised $20M on July 22, 2020.
Who to call at CereVasc, and when
A new round usually means CereVasc is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CereVasc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CereVasc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CereVasc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CereVasc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCereVasc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.